Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C

BACKGROUND/AIMS: This study was performed to evaluate the efficacy of direct-acting antivirals (DAAs) in Korean patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) and to investigate the risk factors associated with HCC recurrence. METHODS: A total of 100 patients with HCV-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Young-Hwan, Lee, Heirim, Kim, Do Young, Lee, Hye Won, Yu, Su Jong, Cho, Young Youn, Jang, Jeong Won, Jang, Byoung Kuk, Kim, Chang Wook, Kim, Hee Yeon, Park, Hana, Cho, Hyo Jung, Park, Bumhee, Kim, Soon Sun, Cheong, Jae Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129654/
https://www.ncbi.nlm.nih.gov/pubmed/32893194
http://dx.doi.org/10.5009/gnl20151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129654/
https://www.ncbi.nlm.nih.gov/pubmed/32893194
http://dx.doi.org/10.5009/gnl20151

Ejemplares similares